Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Ferrante

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Cancer Chemotherapy and Pharmacology|June 5, 1999
Promising new developments in cancer chemotherapyK Ferrante, B Winograd, R Canetta
The American Journal of Gastroenterology|August 1, 1995
Treatment of hepatocellular carcinoma with transjugular intrahepatic portosystemic shunting and chemoembolizationK Stuart, H Anastopoulos, K Ferrante, et al.
Neurology|February 9, 2005
Detection of serum reverse transcriptase activity in patients with ALS and unaffected blood relativesA J Steele, A Al-Chalabi, K Ferrante, et al.
Cancer|July 11, 1998
A phase II trial of 5-fluorouracil, leucovorin, and carboplatin in patients with unresectable biliary tree carcinomaP M Sanz-Altamira, K Ferrante, R L Jenkins, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 4, 2001
Phase I and pharmacologic study of OSI-774, an epidermal growth factor receptor tyrosine kinase inhibitor, in patients with advanced solid malignanciesM Hidalgo, L L Siu, J Nemunaitis, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Cancer Chemotherapy and Pharmacology|June 5, 1999
Promising new developments in cancer chemotherapyK Ferrante, B Winograd, R Canetta
The American Journal of Gastroenterology|August 1, 1995
Treatment of hepatocellular carcinoma with transjugular intrahepatic portosystemic shunting and chemoembolizationK Stuart, H Anastopoulos, K Ferrante, et al.
Neurology|February 9, 2005
Detection of serum reverse transcriptase activity in patients with ALS and unaffected blood relativesA J Steele, A Al-Chalabi, K Ferrante, et al.
Cancer|July 11, 1998
A phase II trial of 5-fluorouracil, leucovorin, and carboplatin in patients with unresectable biliary tree carcinomaP M Sanz-Altamira, K Ferrante, R L Jenkins, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 4, 2001
Phase I and pharmacologic study of OSI-774, an epidermal growth factor receptor tyrosine kinase inhibitor, in patients with advanced solid malignanciesM Hidalgo, L L Siu, J Nemunaitis, et al.
Pageof 1